pexidartinib
CHEBI:CHEBI_145373
Definition
A pyrrolopyridine that is 5-chloro-1H-pyrrolo[2,3-b]pyridine which is substituted by a [6-({[6-(trifluoromethyl)pyridin-3-yl]methyl}amino)pyridin-3-yl]methyl group at position 3. It is a potent multi-targeted receptor tyrosine kinase inhibitor of CSF-1R, KIT, and FLT3 (IC50 of 20 nM, 10 nM and 160 nM, respectively). Approved by the FDA for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT).
Chemical Information
- Molecular Formula
- C20H15ClF3N5
- Molecular Mass
- 417.820
- Charge
- 0
- SMILES
- C1=C(C=C2C(=N1)NC=C2CC3=CN=C(C=C3)NCC4=CC=C(N=C4)C(F)(F)F)Cl
- InChI
- InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)
- InChIKey
- JGWRKYUXBBNENE-UHFFFAOYSA-N
Alternative Names
- 5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-{[6-(trifluoromethyl)pyridin-3-yl]methyl}pyridin-2-amine
- CML-261
- pexidartinib
- pexidartinibum
- PLX-3397
- PLX3397
- Turalio
Drug Classification
-
organochlorine compoundView Class →
CHEBI:36683
-
organofluorine compoundView Class →
CHEBI:37143
-
aminopyridineView Class →
CHEBI:38207
-
secondary amino compoundView Class →
CHEBI:50995
-
pyrrolopyridineView Class →
CHEBI:46771
-
t111654
-
t111788
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:145373
- DRON_00010000
- 2183102
- oboInOwl#hasDbXref
- Wikipedia:Pexidartinib
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- core#notation
- CHEBI:145373
- pharm_class
- Kinase Inhibitors [MoA]
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 2183102
- oboInOwl#hasDbXref
- Wikipedia:Pexidartinib
- oboInOwl#id
- CHEBI:145373
- brand_name
- Turalio
- brand_name_base
- Turalio
- rxcui
- 2626399
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- listing_expiration_date
- 20251231
- route
- ORAL
- dosage_form
- CAPSULE
- active_ingredient_strength
- 20 kg/20kg
- marketing_start_date
- 20190805
- package_marketing_start_date
- 14-OCT-22
- labeler_name
- Daiichi Sankyo, Inc.
- generic_name
- Pexidartinib HCl
- product_ndc
- 50384-0750
- spl_id
- c96330e8-d8f5-5fc6-e053-2a95a90abe24
- active_ingredient_name
- PEXIDARTINIB HYDROCHLORIDE
- package_ndc
- 50384-0750-0
- package_description
- 20 kg in 1 DRUM (50384-0750-0)
- application_number
- NDA211810
- manufacturer_name
- Daiichi Sankyo, Inc.
- unii
- YS6WAI3XN7
- spl_set_id
- 7b0ec4bf-b2ac-49ee-96af-7740ad3f2e16
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_62434
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- has_treatment
- http://purl.obolibrary.org/obo/DOID_2704
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect5354
- owl#annotatedSource
- t112539
- owl#someValuesFrom
- t3463552